| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Jun 9, 2025 | Jun 11, 2025 | Ernexa Therapeutics Inc. | 10% Owner | Buy | 100.0 | +21,241,163 | 104.03% | ✗ | $2.2M |
| Apr 2, 2025 | Apr 4, 2025 | Ernexa Therapeutics Inc. | 10% Owner | Buy | 97.5 | +3,768,397 | 22.66% | ✗ | $394.2K |
| Dec 2, 2022 | Dec 6, 2022 | Ernexa Therapeutics Inc. | Director | Buy | 97.5 | +261,756 | 88.82% | ✗ | $858.6K |
| Jun 16, 2021 | Jun 21, 2021 | Ernexa Therapeutics Inc. | Director | Sell | 16.3 | -400,000 | -6.36% | ✗ | $6.3M |